| pubmed-article:16390409 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16390409 | lifeskim:mentions | umls-concept:C0010823 | lld:lifeskim |
| pubmed-article:16390409 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16390409 | lifeskim:mentions | umls-concept:C0029216 | lld:lifeskim |
| pubmed-article:16390409 | lifeskim:mentions | umls-concept:C0524930 | lld:lifeskim |
| pubmed-article:16390409 | lifeskim:mentions | umls-concept:C0440790 | lld:lifeskim |
| pubmed-article:16390409 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:16390409 | pubmed:issue | 3-4 | lld:pubmed |
| pubmed-article:16390409 | pubmed:dateCreated | 2006-1-4 | lld:pubmed |
| pubmed-article:16390409 | pubmed:abstractText | Clinical consequences of ganciclovir resistant cytomegalovirus (CMV) infections were studied during 2 large prophylactic trials consisting of 100 days of valganciclovir or ganciclovir prophylaxis in solid organ transplant (SOT) recipients. The first one involved 301 high-risk (CMV donor seropositive/recipient seronegative) SOT recipients excluding lung transplants followed for 12 months, whereas the second one involved 80 lung transplant patients evaluated over 6 months. Among the 7 patients (4 non-lung and 3 lung transplant patients) carrying viruses with known ganciclovir-resistance [corrected] mutations in blood, adverse clinical outcome was only observed in the lung transplant recipients. Additionally, no CMV resistance mutations were observed in non-lung transplant patients receiving valganciclovir. | lld:pubmed |
| pubmed-article:16390409 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16390409 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16390409 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16390409 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16390409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16390409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16390409 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16390409 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16390409 | pubmed:issn | 1398-2273 | lld:pubmed |
| pubmed-article:16390409 | pubmed:author | pubmed-author:BoivinGG | lld:pubmed |
| pubmed-article:16390409 | pubmed:author | pubmed-author:GilbertCC | lld:pubmed |
| pubmed-article:16390409 | pubmed:author | pubmed-author:HumadSS | lld:pubmed |
| pubmed-article:16390409 | pubmed:author | pubmed-author:GoyetteNN | lld:pubmed |
| pubmed-article:16390409 | pubmed:author | pubmed-author:CovingtonEE | lld:pubmed |
| pubmed-article:16390409 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16390409 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:16390409 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16390409 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16390409 | pubmed:pagination | 166-70 | lld:pubmed |
| pubmed-article:16390409 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16390409 | pubmed:meshHeading | pubmed-meshheading:16390409... | lld:pubmed |
| pubmed-article:16390409 | pubmed:meshHeading | pubmed-meshheading:16390409... | lld:pubmed |
| pubmed-article:16390409 | pubmed:meshHeading | pubmed-meshheading:16390409... | lld:pubmed |
| pubmed-article:16390409 | pubmed:meshHeading | pubmed-meshheading:16390409... | lld:pubmed |
| pubmed-article:16390409 | pubmed:meshHeading | pubmed-meshheading:16390409... | lld:pubmed |
| pubmed-article:16390409 | pubmed:meshHeading | pubmed-meshheading:16390409... | lld:pubmed |
| pubmed-article:16390409 | pubmed:meshHeading | pubmed-meshheading:16390409... | lld:pubmed |
| pubmed-article:16390409 | pubmed:meshHeading | pubmed-meshheading:16390409... | lld:pubmed |
| pubmed-article:16390409 | pubmed:meshHeading | pubmed-meshheading:16390409... | lld:pubmed |
| pubmed-article:16390409 | pubmed:meshHeading | pubmed-meshheading:16390409... | lld:pubmed |
| pubmed-article:16390409 | pubmed:meshHeading | pubmed-meshheading:16390409... | lld:pubmed |
| pubmed-article:16390409 | pubmed:articleTitle | Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients. | lld:pubmed |
| pubmed-article:16390409 | pubmed:affiliation | Research Center in Infectious Diseases of the CHUQ-CHUL and Laval University, Quebec City, Quebec, Canada. guy.boivin@crchul.ulaval.ca | lld:pubmed |
| pubmed-article:16390409 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16390409 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:16390409 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16390409 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16390409 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16390409 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16390409 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16390409 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16390409 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16390409 | lld:pubmed |
